In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

The in vitro activities of rufloxacin and its metabolite, MF 922, were compared with those of ofloxacin, ciprofloxacin, erythromycin, and minocycline against Mycoplasma pneumoniae, Mycoplasma hominis, Mycoplasma fermentans, and Ureaplasma urealyticum. Rufloxacin, MF 922, and ciprofloxacin shared sim...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Furneri, P M, Bisignano, G, Cerniglia, G, Nicoletti, G, Cesana, M, Tempera, G
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1994
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188257/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7872762/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.11.2651
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!